Ra Capital Management, L.p. bought $20M of TYRA
director, owner at Tyra Biosciences, Inc.. 1,220,681 shares at an average of $16.25, traded Nov 8, 2024, filed Nov 13, 2024.
Score components
- +15RoleDirector
- +25Trade size$19.8M at market
- +3Relative to holdingsHoldings up 16%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -5.1%, 3m -23.5%, 6m -38.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-026718, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 8, 2024 | POpen-market purchase Common Stockindirect: See footnotes | +1,220,681 | $16.25 | $20M | 8,697,956 | Nov 13, 2024 |
Related signals
Other insiders at Tyra Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | TYRAbuy Tyra Biosciences, Inc. | Rehan Verjee director | $20k 972 shares | - | |
| 23Weak | TYRAsell Tyra Biosciences, Inc. | Nina S Kjellson director | $74k 5,401 shares | -0% | |
| 24Weak | TYRAsell Tyra Biosciences, Inc. | Nina S Kjellson director | $78k 4,825 shares | -0% | |
| 31Weak | TYRAsell Tyra Biosciences, Inc. | Nina S Kjellson director | $410k 25,041 shares | -1% | |
| 24Weak | TYRAsell Tyra Biosciences, Inc. | Nina S Kjellson director | $89k 5,272 shares | -0% | |
| 40Moderate | TYRAsell Tyra Biosciences, Inc. | Nina S Kjellson director | $1.3M 74,582 shares | -2% | |
| 27Weak | TYRAsell Tyra Biosciences, Inc. | Nina S Kjellson director | $194k 11,569 shares | -0% | |
| 51Moderate | Tyra Biosciences, Inc. | Alan Fuhrman Chief Financial Officer | $152k 9,500 shares | +284% | |
| 48Moderate | Tyra Biosciences, Inc. | Nina S Kjellson director | $2.3M 138,711 shares | -4% | |
| 38Weak | Tyra Biosciences, Inc. | Todd Harris President and CEO | $1.7M 62,720 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.